Dec 18, 2024
PRESS RELEASE: We’re excited to formally announce our exclusive distributionship with Vita Analytica. As part of this agreement, we will supply Vita with the full suite of our Proteonano™ Ultraplex Proteomics Platform to support the standardization of its omics services platforms and enable deeper, reproducible fluids & FFPE proteome profiling.
Hangzhou | Sydney, 18 December 2024: We are pleased to announce a strategic partnership between Nanomics Biotech and Vita Analytics, making Vita Analytics our exclusive distributor in Australia. This collaboration marks a significant milestone as we continue to expand our global presence and advance the field of proteomics.
Strategic Importance of the Partnership
Nanomics Biotech is committed to empowering researchers and clinicians with state-of-the-art technologies that drive scientific discovery and precision medicine. By partnering with Vita Analytics, we are bringing our cutting-edge Proteonano™ platform to the Australian market, providing access to comprehensive proteomics solutions that will support advancements in areas such as biomarker discovery, disease detection, and clinical research.
“Together, we’ll push the boundaries of proteomics, opening up new opportunities for scientific breakthroughs and clinical advancements. Our goal to transform healthcare with cutting-edge technology is stronger than ever, and this collaboration will make a real difference for researchers and clinicians in Australia and beyond." — Dr. Wu Hao, CEO, Nanomics Biotech
Vita Analytics, with its extensive local expertise and established presence in the Australian market, is the ideal partner to help us achieve these goals. Their deep understanding of the needs of local research institutions and healthcare professionals will enable us to accelerate the adoption of our platform and ensure it has a meaningful impact on the scientific community in Australia.
Looking Ahead
This partnership represents a new phase in our commitment to providing innovative proteomics solutions worldwide. We are excited about the opportunities it will create for Australian researchers and clinicians, and we look forward to collaborating with Vita Analytics to drive scientific breakthroughs and enhance the quality of clinical outcomes.
Stay tuned for further updates on this exciting journey as we work together to transform proteomics research in Australia.
Here’s to a bright future ahead.